For example, certain genetic profiles may suggest earlier consideration of dual-compound therapy, or conversely, may indicate standard dosing is sufficient
2024;45 doi: 10.1016/j.pmedr.2024.102845
Research suggests it may inhibit NNMT (Nicotinamide N-Methyltransferase), an enzyme linked to metabolic rate and fat cell energy regulation
Michael Lincoff, M.D., Kirstine Brown-Frandsen, M.D., et al
Dludla Life Sciences.2022
Body Protection Compound-157 (BPC-157) earned the "healing peptide" label through its broad, multi-system reparative activity observed across preclinical models, covering muscle, tendon, ligament, bone, and gastrointestinal tissue repair